ARVN003

ARVN003, known as MicroLine in US, is a pharmacologic treatment for presbyopia developed by Eyenovia, Inc. (NASDAQ: EYEN). Current treatment options for presbyopia are typically device-based, such as reading glasses and contact lenses. Pilocarpine ophthalmic solution is known to constrict the pupil and improve near-distance vision by creating an extended depth of focus through its small aperture effect. 

We believe that administration of pilocarpine using the Eyenovia's high precision microdosing technology (MAP™) could provide a meaningful improvement in near vision while enhancing tolerability and usability.

ADDRESS
Suite 1732, 17F, Tower 1, Century Link, 1198 Century Avenue, Pudong New District, Shanghai, China
SUBSCRIBE TO OUR NEWSLETTER
Subscribe
Copyright © 2020 Arctic Vision (Shanghai) Biotechnology Co., Ltd.